4 results
The primary objective of this first-in-man safety and feasibility study is to assess the safety of the Volcano PreView FL.IVUS catheter when used after successful coronary stenting.
to study the safety and tolerability of HM10660A (LAPS-interferon alpha-2b), including immunogenicity, as compared to Pegasys® (PEG-interferon alpha-2a)to study the pharmacokinetics and pharmacodynamics of HM10660A (LAPS interferon alpha-2b) as…
To establish the safety and tolerablity of multiple doses of hLF1-11 given once daily for 10 days.
The primary objective of this study is to evaluate the safety and antiviral efficacy, defined as the percentage of subjects with sustained virologic response 12 weeks post-dosing (SVR12; HCV RNA < LLOQ 12 weeks after the last dose of study…